Abstract:Dependence and impairment of learning and memory are two well-established features caused by abused drugs such as opioids. The hippocampus is an important region associated with both drug dependence and learning and memory. However, the molecular events in hippocampus following exposure to abused drugs such as opioids are not well understood. Here we examined the effect of chronic morphine treatment on hippocampal protein expression by proteomic analyses. We found that chronic exposure of mice to morphine for 10 days produced robust morphine withdrawal jumping and memory impairment, and also resulted in a significant downregulation of hippocampal protein levels of three metabolic enzymes, including Fe-S protein 1 of NADH dehydrogenase, dihydrolipoamide acetyltransferase or E2 component of the pyruvate dehydrogenase complex and lactate dehydrogenase 2. Further real-time quantitative PCR analyses confirmed that the levels of the corresponding mRNAs were also remarkably reduced. Consistent with these findings, lower ATP levels and an impaired ability to convert glucose into ATP were also observed in the hippocampus of chronically treated mice. Opioid antagonist naltrexone administrated concomitantly with morphine significantly suppressed morphine withdrawal jumping and reversed the downregulation of these proteins. Acute exposure to morphine also produced robust morphine withdrawal jumping and significant memory impairment, but failed to decrease the expression of these three proteins. Intrahippocampal injection of D-glucose before morphine administration significantly enhanced ATP levels and suppressed morphine withdrawal jumping and memory impairment in acute morphine-treated but not in chronic morphine-treated mice. Intraperitoneal injection of high dose of D-glucose shows a similar effect on morphine-induced withdrawal jumping as the central treatment. Taken together, our results suggest that reduced expression of the three metabolic enzymes in the hippocampus as a result of chronic morphine treatment contributes to the development of drug-induced symptoms such as morphine withdrawal jumping and memory impairment.

Chronic morphine administration induces over-expression of aldolase C with reduction of CREB phosphorylation in the mouse hippocampus.

Morphine Epigenomically Regulates Behavior Through Alterations in Histone H3 Lysine 9 Dimethylation in the Nucleus Accumbens

Inhibition of SNAP-25 Phosphorylation at Ser187 is Involved in Chronic Morphine-induced Down-regulation of SNARE Complex Formation

Modulation of Ca2+/calmodulin-dependent Protein Kinase II Activity by Acute and Chronic Morphine Administration in Rat Hippocampus: Differential Regulation of Alpha and Beta Isoforms.

Alterations in phosphorylated CREB expression in different brain regions following short- and long-term morphine exposure: relationship to food intake

Expression Changes of Hippocampal Energy Metabolism Enzymes Contribute to Behavioural Abnormalities During Chronic Morphine Treatment

Chronic exposure to morphine decreases the expression of EAAT3 via opioid receptors in hippocampal neurons.

Effects of chronic morphine treatment on protein expression in rat dorsal root ganglia.

Naloxone-precipitated withdrawal enhances ERK phosphorylation in prefrontal association cortex and accumbens nucleus of morphine-dependent mice.

Morphine-Driven m6A Epitranscriptomic Neuroadaptations in Primary Cortical Cultures

Chronic Morphine Treatment Switches The Effect Of Dopamine On Excitatory Synaptic Transmission From Inhibition To Excitation In Pyramidal Cells Of The Basolateral Amygdala

Morphine modulates glutamate release in the hippocampal CA1 area in mice.

Chronic, but Not Acute Morphine Treatment, Up-regulates α-Ca 2+ /calmodulin Dependent Protein Kinase II Gene Expression in Rat Brain

Regional Expression of Extracellular Signal-Regulated Kinase 1 and 2 Mrna in a Morphine-Induced Conditioned Place Preference Model.

Effects of the altered activity of δ-opioid receptor on the expression of glutamate transporter type 3 induced by chronic exposure to morphine.

Two Kinds of Transcription Factors Mediate Chronic Morphine-Induced Decrease in Mir-105 in Medial Prefrontal Cortex of Rats

Altered phosphorylation of GluA1 in the striatum is associated with locomotor sensitization induced by exposure to increasing doses of morphine.

INVOLVEMENT OF ATTENUATION OF Na + , K + -ATPase ACTIVITY AND DECREMENT OF ENERGY METABOLISM ENZYME EXPRESSION IN THE DEVELOPMENT OF MORPHINE DEPENDENCE

Naloxone reversed cognitive impairments induced by repeated morphine under heavy perceptual load in the 5-choice serial reaction time task.

Chronic morphine treatment impaired hippocampal long-term potentiation and spatial memory via accumulation of extracellular adenosine acting on adenosine A1 receptors

Chronic morphine selectively sensitizes the effect of D1 receptor agonist on presynaptic glutamate release in basolateral amygdala neurons that project to prelimbic cortex.